Pfizer

Pfizer’s COVID-19 vaccine trial data shows long-term efficacy in adolescents

November 23, 2021

Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15 years, Reuters reported. A two-dose series of the vaccine was 100% effective against COVID-19, measured seven days through over four months after the...

All children above 12 yo to be jabbed with Pfizer vaccine from November 14

All children above 12 yo to be jabbed with Pfizer vaccine from November 14

The emergence and spread of Coronavirus variants – CAN VACCINES FAIL?

The emergence and spread of Coronavirus variants – CAN VACCINES FAIL?

Pfizer and AstraZeneca vaccine slowdown delays threaten Europe’s recovery

Pfizer and AstraZeneca vaccine slowdown delays threaten Europe’s recovery

Coronavirus VACCINE Explainer – Sifting facts from fiction

Coronavirus VACCINE Explainer – Sifting facts from fiction

Covid Vaccines may be LESS EFFECTIVE against NEW virus variants

Covid Vaccines may be LESS EFFECTIVE against NEW virus variants

Pfizer vaccine deaths among elderly may be pointing to a wrong strategy

Pfizer vaccine deaths among elderly may be pointing to a wrong strategy

TRENDING